# FDA 483 - Children's Hospital - June 13, 2025

Source: https://www.keypedia.com/records/483/childrens-hospital/4e8e1c69-2260-4550-ad6c-7a9a8df2292a

> FDA 483 for Children's Hospital on June 13, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Children's Hospital
- Inspection Date: 2025-06-13
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: Manning Family Children's in New Orleans, LA, an HCT/P and Blood Bank, was cited with two observations during an FDA inspection. The firm failed to validate critical cord blood processing methods, including those intended to prevent communicable disease transmission and ensure disinfectant efficacy. Additionally, the firm did not meet specified in-process control requirements, with documentation discrepancies noted regarding cord blood unit processing.

## Related Officers

- [Amy A. Johnson](https://www.keypedia.com/people/amy-a-johnson/9933f793-503f-45c5-8837-d46134c20e09)

Company: https://www.keypedia.com/companies/childrens-hospital/4a562f65-bd8b-4693-9c5a-9bf9f92f5ea5

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea